Market Insights Health OTC Pharmaceuticals

Analgesics - Poland

Poland

In Poland, the revenue in the Analgesics market is projected to reach US$0.81bn in 2024.
It is anticipated that the market will experience a yearly growth rate of 9.24% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,243.00m in 2024.
On a per person basis, the revenue generated in Poland in 2024 is approximately US$20.11.
Poland's analgesic market is witnessing a growing demand for over-the-counter pain relief medications due to increasing health consciousness and self-medication trends.

Key regions: Brazil, Europe, Germany, Canada, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Poland has been experiencing steady growth in recent years, driven by several key factors.

Customer preferences: Polish consumers have shown a growing preference for over-the-counter (OTC) analgesics, as they offer convenience and accessibility without the need for a prescription. This trend is in line with global market preferences, as consumers increasingly seek self-care options for minor ailments. Additionally, there is a growing awareness among Polish consumers about the importance of pain management and the availability of effective analgesic products.

Trends in the market: One of the key trends in the Analgesics market in Poland is the increasing demand for non-opioid analgesics. This can be attributed to the rising concerns about the misuse and addiction potential of opioid-based pain medications. As a result, consumers are turning to safer alternatives such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. This trend is also influenced by the regulatory environment, as authorities are implementing stricter controls on opioid prescriptions.Another trend in the market is the growing popularity of topical analgesics. These products offer localized pain relief and are preferred by consumers for conditions such as muscle and joint pain. The ease of application and targeted relief provided by topical analgesics make them a convenient choice for consumers.

Local special circumstances: Poland has a rapidly aging population, which has contributed to the increased demand for analgesics. As people age, they are more likely to experience chronic pain conditions such as arthritis, which require long-term pain management. This demographic factor has created a sustained demand for analgesics in the country.Furthermore, the Polish healthcare system has undergone significant reforms in recent years, leading to increased access to healthcare services and medications. This has resulted in a higher number of patients seeking treatment for pain-related conditions and consequently driving the demand for analgesics.

Underlying macroeconomic factors: Poland has experienced steady economic growth in recent years, which has positively impacted the healthcare sector. With a growing middle class and increasing disposable income, consumers have more purchasing power to spend on healthcare products, including analgesics. This economic stability has created a favorable environment for the growth of the Analgesics market in Poland.In conclusion, the Analgesics market in Poland is witnessing growth due to customer preferences for OTC options, the increasing demand for non-opioid analgesics, and the popularity of topical analgesics. The local special circumstances of an aging population and healthcare reforms have also contributed to the market's development. Additionally, the underlying macroeconomic factors, such as steady economic growth and rising disposable income, have further fueled the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.